Key result
Targeted inhibition of calcineurin by Cabin 1 over-expression or cyclosporin A inhibited the production of IL-6 and MMP-2 by rheumatoid synoviocytes.
Abnormal activation of calcineurin in synoviocytes contributes to chronic arthritis pathogenesis, suggesting it as a potential therapeutic target.
Answers are grounded in this paper and cite their sources.
Calcineurin inhibition merits exploration in rheumatoid arthritis; animal data leave open clinical translation and require human trials.
Calcineurin plays a crucial role in T cell activation, cell growth, apoptosis, and angiogenesis, and its over-expression has been implicated in the pathogenesis of cardiomyopathy and stroke. However, the expression and function of calcineurin in the pathologic lesion of chronic inflammatory diseases, like rheumatoid synovium, remain to be defined. This study was aimed to determine the role of calcineurin in inflammatory arthritis and investigate the expression and function of calcineurin in the rheumatoid synovium and synoviocytes, the actual site of chronic inflammation. Methods: Immuno-histochemical staining using specific antibody to calcineurin was perfomed in the synovium of rheumatoid arthritis (RA). Fibroblast-like synoviocytes (FLS) from RA and osteoarthritis (OA) patients were isolated from RA and OA patients, and cultured with IL-1β and TNF-α in the presence or absence of cyclosporin A, a calcineurin inhibitor. The calcineurin expression was assessed by phosphatase assay and Western blotting analysis. IL-6, -10, -17, matrix metalloproteinase (MMP)-1, -2, -3, and -9 released into the culture supernatants were measured by ELISA. After transfection with GFP-Cabin 1 gene into synoviocytes, the levels of IL-6 and MMPs were measured by ELISA. Results: Calcineurin was highly expressed in the lining layer of synovium and cultured synoviocytes of RA patients. The elevated calcineurin activity in the rheumatoid synoviocytes was triggered by proin flammatory cytokines such as IL-1β and TNF-α. In contrast, IL-10, an anti-inflammatory cytokine, failed to increase the calcineurin activity. The targeted inhibition of calcineurin by the over-expression of Cabin 1, a natural calcineurin antagonist, inhibited the production of IL-6 and MMP-2 by rheumatoid synoviocytes in a similar manner to the calcineurin inhibitor, cyclosporin A. Conclusion: These data suggest that abnormal activation of calcineurin in the synoviocytes may contribute to the pathogenesis of chronic arthritis, and thus provide a potential target for controlling inflammatory arthritis.
No takes yet. Share an insight, caveat, or question.
Park et al. (2006) studied Rheumatoid arthritis and osteoarthritis. Cyclosporin A or Cabin 1 gene transfection vs. Absence of cyclosporin A or untransfected was evaluated on Production of IL-6 and MMP-2. Targeted inhibition of calcineurin by Cabin 1 over-expression or cyclosporin A inhibited the production of IL-6 and MMP-2 by rheumatoid synoviocytes.
Synapse has enriched 10 related papers. Consider them for comparative context: